You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 6, December 1949 TABLE OF CONTENTS
  Archives
  •  Online Features
  Active Immunization Against Secondary Bacterial Infections of the Common Cold
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

ACTIVE IMMUNIZATION AGAINST SECONDARY BACTERIAL INFECTIONS OF THE COMMON COLD

Production of Protective Antibodies in Human Adults by the Oral Administration of Stock Polyvalent Bacterial Vaccines

JOHN A. KOLMER, M.D.; AMEDEO BONDI, Jr., Ph.D.; CLARE SCHILLINGER, B.S.

Arch Otolaryngol. 1949;50(6):693-699.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AS PREVIOUSLY reported,1 the oral administration to mice of stock polyvalent vaccines prepared from the desiccated organisms and their soluble products commonly involved in the secondary bacterial infections of the common cold has been found effective in the active immunization of some of these animals against virulent hemolytic streptococci, pneumococci of types I, II and III, Klebsiella pneumoniae and Staphylococcus aureus. The investigations of Thomson and Thomson2 have also shown that such vaccines may be absorbed after oral administration to human beings, in whom agglutinins are then produced. Ross3 has likewise found that the oral administration of vaccines of pneumococci to human beings not only is well borne but quickly produces immunity, since protective antibodies against the type I pneumococcus were found in the serums of 75 per cent of subjects and against types II and III pneumococci in the serums of about 60 per cent. Thomson. . . . [Full Text PDF of this Article]


Author Affiliations

With the Technical Assistance of Anna M. Rule PHILADELPHIA

From the Department of Bacteriology and Immunology of Temple University School of Medicine and the Research Institute of Cutaneous Medicine.


Footnotes

This investigation was aided by a grant from the Wm. S. Merrell Company, Cincinnati, Ohio.

The present address of Dr. Bondi and Miss Schillinger is Hahnemann Medical College, Philadelphia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1949 American Medical Association. All Rights Reserved.